Gene · 4200
Papers3,297
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,297
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome Analysis Reveals an Eicosapentaenoic Acid Accumulation Mechanism in a Schizochytrium sp. Mutant. | Microbiol Spectr | 2023 | 37093006 | PubTator, text mining | PubMed |
| Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia. | Cell Oncol (Dordr) | 2023 | 37079187 | PubTator, text mining | PubMed |
| Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer's disease biomarkers. | Cell Rep Med | 2023 | 37075703 | PubTator, text mining | PubMed |
| Role of asparagine biosynthesis pathway in Siniperca chuatsi rhabdovirus proliferation. | Front Microbiol | 2023 | 37065159 | PubTator, text mining | PubMed |
| Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer. | Front Pharmacol | 2023 | 37063293 | PubTator, text mining | PubMed |
| C/EBPβ-LIP mediated activation of the malate-aspartate shuttle sensitizes cells to glycolysis inhibition. | Mol Metab | 2023 | 37062524 | PubTator, text mining | PubMed |
| IDH3γ functions as a redox switch regulating mitochondrial energy metabolism and contractility in the heart. | Nat Commun | 2023 | 37055412 | PubTator, text mining | PubMed |
| The RNA-Binding and RNA-Melting Activities of the Multifunctional Protein Nucleobindin 1. | Int J Mol Sci | 2023 | 37047165 | PubTator, text mining | PubMed |
| Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer. | Cancers (Basel) | 2023 | 37046596 | PubTator, text mining | PubMed |
| New insights into posttranslational modifications of proteins during bull sperm capacitation. | Cell Commun Signal | 2023 | 37046330 | PubTator, text mining | PubMed |
| Plasmodium Parasite Malate-Quinone Oxidoreductase Functionally Complements a Yeast Deletion Mutant of Mitochondrial Malate Dehydrogenase. | Microbiol Spectr | 2023 | 37036365 | PubTator, text mining | PubMed |
| Tat-malate dehydrogenase fusion protein protects neurons from oxidative and ischemic damage by reduction of reactive oxygen species and modulation of glutathione redox system. | Sci Rep | 2023 | 37024665 | PubTator, text mining | PubMed |
| The KMT2A recombinome of acute leukemias in 2023. | Leukemia | 2023 | 37019990 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Cholesterol: An Important Determinant of Muscle Atrophy in Astronauts. | J Biotechnol Biomed | 2023 | 37006714 | PubTator, text mining | PubMed |
| Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer. | Front Immunol | 2023 | 37006282 | PubTator, text mining | PubMed |
| MitoEVs: A new player in multiple disease pathology and treatment. | J Extracell Vesicles | 2023 | 37002588 | PubTator, text mining | PubMed |
| Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes. | Front Immunol | 2023 | 36999013 | PubTator, text mining | PubMed |
| Amino acid metabolic reprogramming in tumor metastatic colonization. | Front Oncol | 2023 | 36998464 | PubTator, text mining | PubMed |
| Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy. | Metabolites | 2023 | 36984809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4200/papers?page=16